ARCHIVES

Methylene Chloride Mortality Study Approved By DCE board

This article is from The Cancer Letter archive.

Vol. 12 No. 26 | June 27, 1986

Download PDF Visit The Full Archive

Related Articles

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

Phase III Trial Retrospective Analysis Finds Talimogene Laherparepvec Reduced Tumors

March 28, 2014

IOM Selects Advisors To Defense Department

February 5, 1993

How Low Can You Go? ODAC Accepts Retrospective Study for Accelerated Approval

September 30, 2011

Otis Brawley To Succeed Harmon Eyre As American Cancer Society’s Chief Medical Officer.

August 3, 2007

Study Identifies Characteristics That Promote Early-Life NHL

May 25, 2012